Dose escalation offers no survival benefits but increases grade ≥ 3 toxicity compared with standard radiation in patients ...

The company's efforts aim to promote awareness and education about esophageal cancer, a disease with a five-year survival rate of approximately 20%, according to Emmanuel Gorospe, M.D., of Castle ...

FRIENDSWOOD, Texas, April 08, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, is supporting key ...

The Company is proudly collaborating with the Esophageal Cancer Action Network (ECAN), the American Foregut Society (AFS) and The Gut Doctor Podcast LLC to promote esophageal cancer prevention ...

Rice-led study serves as foundation for FDA investigational new drug application and emerging new company to launch from RBL LLC HOUSTON, April 8, 2025 /PRNewswire/ -- A team of researchers from ...

The state Department of Public Health is “in communication” with Newton-Wellesley Hospital after a reported group of nurses were diagnosed with brain tumors. The diagnosed nurses have worked ...

This Tpex cell recruitment results in a large, durable population of tumor-targeting T cells with broad molecular profiles, both in isolation and in an enhanced manner when implemented in ...

1University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Teddi Mellencamp confirmed she has stage 4 cancer after doctors found more tumors in her brain. “I woke up to so many kind messages,” the former “Real Housewives of Beverly Hills” star ...